Regulus Therapeutics
RGLS
#8761
Rank
โ‚ฌ96.24 M
Marketcap
1,47ย โ‚ฌ
Share price
10.64%
Change (1 day)
16.35%
Change (1 year)

Revenue for Regulus Therapeutics (RGLS)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Regulus Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 โ‚ฌ8.13 M33.39%
2019 โ‚ฌ6.09 M9590.19%
2018 โ‚ฌ0.06 M4.88%
2017 โ‚ฌ0.06 M-94.71%
2016 โ‚ฌ1.13 M-94.02%
2015 โ‚ฌ18.98 M201.09%
2014 โ‚ฌ6.3 M-55.5%
2013 โ‚ฌ14.17 M47.59%
2012 โ‚ฌ9.6 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ37.91 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ50.39 BN/A๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ9.11 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ46.27 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ1.97 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.56 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ44.67 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.18 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA